| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.082 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |